Ageing Research Reviews,
Journal Year:
2022,
Volume and Issue:
79, P. 101648 - 101648
Published: May 18, 2022
After
fifteen
years
of
genome-wide
association
studies
(GWAS)
in
Parkinson's
disease
(PD),
what
have
we
learned?
Addressing
this
question
will
help
catalogue
the
progress
made
towards
elucidating
mechanisms,
improving
clinical
utility
identified
loci,
and
envisioning
how
can
harness
strides
to
develop
translational
GWAS
strategies.
Here
review
advances
PD
date
while
critically
addressing
challenges
opportunities
for
next-generation
GWAS.
Thus,
deciphering
missing
heritability
underrepresented
populations
is
currently
at
reach
hand
a
truly
comprehensive
understanding
genetics
across
different
ethnicities.
Moreover,
state-of-the-art
designs
hold
true
potential
enhancing
applicability
genetic
findings,
instance,
by
prediction
(PD
risk
progression).
Lastly,
advanced
alone
or
combination
with
environmental
parameters,
are
expected
capacity
defining
patient
enriched
cohorts
stratified
profiles
readily
available
neuroprotective
trials.
Overall,
future
strategies
timely
be
instrumental
providing
novel
readouts
essential
translatability
findings.
Environment International,
Journal Year:
2022,
Volume and Issue:
170, P. 107635 - 107635
Published: Nov. 16, 2022
Given
the
increasing
burden
of
chronic
conditions,
multimorbidity
is
now
a
priority
for
public
health
systems
worldwide.
However,
relationship
between
household
air
pollution
(HAP)
exposure
with
remains
unclear.We
used
three
waves
data
(2011,
2013,
and
2015)
including
19,295
participants
aged
≥
45
years
from
China
Health
Retirement
Longitudinal
Study,
to
investigate
association
HAP
solid
fuel
use
heating
cooking
risk
multimorbidity.
Multimorbidity
was
defined
as
coexistence
two
or
more
15
diseases
(hypertension,
diabetes,
dyslipidemia,
heart
disease,
stroke,
cardiovascular
lung
asthma,
kidney
liver
digestive
cancer,
psychiatric
memory-related
arthritis).
Multiple
logistic
regression
investigated
cooking,
separately
simultaneously,
Poisson
quasi-likelihood
estimation
explored
whether
could
increase
number
morbidities.
Stratified
analyses
sensitivity
examined
effect
modification
robustness
association.Of
(mean
age:
58.9
years),
40.9
%
have
Compared
who
clean
fuels
higher
in
mixed
(adjusted
odds
ratio,
aOR
=
1.26,
95
%CI:1.16-1.36)
users
(aOR
1.81,
1.67-1.98)
separately.
positively
associated
an
increased
morbidities
β
0.329,
0.290
0.368),
after
controlling
confounders.
Those
living
one-story
building,
poor
cleanliness
No
significant
modifications
those
associations
by
socio-demographic
behaviour
characteristics
observed.HAP
high
Chinese
adults.
Our
findings
provide
important
implications
reducing
disease
restricting
use.
Frontiers in Aging Neuroscience,
Journal Year:
2022,
Volume and Issue:
14
Published: July 26, 2022
Parkinson's
disease
(PD)
is
the
second
most
common
neurodegenerative
after
Alzheimer's
disease,
with
typical
motor
symptoms
as
main
clinical
manifestations.
At
present,
there
are
about
10
million
patients
PD
in
world,
and
its
comorbidities
complications
numerous
incurable.
Therefore,
it
particularly
important
to
explore
pathogenesis
of
find
possible
therapeutic
targets.
Because
etiology
complex,
involving
genes,
environment,
aging,
finding
factors
key
identifying
intervention
Hypoxia
ubiquitous
natural
environment
states,
considered
be
closely
related
PD.
Despite
research
showing
that
hypoxia
increases
expression
aggregation
alpha-synuclein
(α-syn),
pathogenic
protein,
still
a
lack
systematic
studies
on
role
α-syn
pathology
pathogenesis.
Considering
inextricably
linked
various
causes
PD,
may
co-participant
many
aspects
pathologic
process.
In
this
review,
we
describe
risk
for
discuss
inducing
by
these
factors.
Furthermore,
attribute
pathological
changes
caused
oxygen
uptake
disorder
utilization
disorder,
thus
emphasizing
possibility
critical
link
initiating
or
promoting
Our
study
provides
novel
insight
exploring
targets
Ageing Research Reviews,
Journal Year:
2022,
Volume and Issue:
79, P. 101648 - 101648
Published: May 18, 2022
After
fifteen
years
of
genome-wide
association
studies
(GWAS)
in
Parkinson's
disease
(PD),
what
have
we
learned?
Addressing
this
question
will
help
catalogue
the
progress
made
towards
elucidating
mechanisms,
improving
clinical
utility
identified
loci,
and
envisioning
how
can
harness
strides
to
develop
translational
GWAS
strategies.
Here
review
advances
PD
date
while
critically
addressing
challenges
opportunities
for
next-generation
GWAS.
Thus,
deciphering
missing
heritability
underrepresented
populations
is
currently
at
reach
hand
a
truly
comprehensive
understanding
genetics
across
different
ethnicities.
Moreover,
state-of-the-art
designs
hold
true
potential
enhancing
applicability
genetic
findings,
instance,
by
prediction
(PD
risk
progression).
Lastly,
advanced
alone
or
combination
with
environmental
parameters,
are
expected
capacity
defining
patient
enriched
cohorts
stratified
profiles
readily
available
neuroprotective
trials.
Overall,
future
strategies
timely
be
instrumental
providing
novel
readouts
essential
translatability
findings.